Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1987 1
1989 1
1992 3
1993 1
1994 1
1995 9
1996 9
1997 7
1998 11
1999 5
2000 9
2001 14
2002 11
2003 8
2004 6
2005 11
2006 9
2007 11
2008 15
2009 8
2010 10
2011 7
2012 1
2013 4
2014 4
2015 2
2016 3
2019 1
2020 1
2021 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW, Rocha MG; SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group. Riker RR, et al. Among authors: whitten p. JAMA. 2009 Feb 4;301(5):489-99. doi: 10.1001/jama.2009.56. Epub 2009 Feb 2. JAMA. 2009. PMID: 19188334 Clinical Trial.
The State and Sustainability of Telepsychiatry Programs.
Lauckner C, Whitten P. Lauckner C, et al. Among authors: whitten p. J Behav Health Serv Res. 2016 Apr;43(2):305-18. doi: 10.1007/s11414-015-9461-z. J Behav Health Serv Res. 2016. PMID: 25794639 Free PMC article. Review.
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL; Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group. Aref AA, et al. JAMA Ophthalmol. 2021 Dec 1;139(12):1285-1291. doi: 10.1001/jamaophthalmol.2021.4395. JAMA Ophthalmol. 2021. PMID: 34709363 Free PMC article. Clinical Trial.
Reproductive actions of phytoestrogens.
Whitten PL, Naftolin F. Whitten PL, et al. Baillieres Clin Endocrinol Metab. 1998 Dec;12(4):667-90. doi: 10.1016/s0950-351x(98)80010-4. Baillieres Clin Endocrinol Metab. 1998. PMID: 10384819 Review.
Electronic health.
Chen H, Nicogossian A, Olsson S, Rafiq A, Stachura ME, Watanabe M, Whitten P, Xiao Y. Chen H, et al. Among authors: whitten p. Int J Telemed Appl. 2009;2009:308710. doi: 10.1155/2009/308710. Epub 2009 Mar 30. Int J Telemed Appl. 2009. PMID: 19343190 Free PMC article. No abstract available.
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.
Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Study Investigator Group. Scott IU, et al. JAMA Ophthalmol. 2022 May 1;140(5):458-464. doi: 10.1001/jamaophthalmol.2022.0352. JAMA Ophthalmol. 2022. PMID: 35323843 Free PMC article. Clinical Trial.
Memorable telemedicine experiences.
Wooton R, Krupinski E, Hailey D, Patterson V, Scott R, Whited J, Whitten P, Yoo S, Hui E, Ferguson J, Van Der Westhuyzen J, Kayser K, Mars M, Martin-Khan M, Tachakra S, Scalvini S, Shumack S, Smith A, Soyer HP, Stachura M. Wooton R, et al. Among authors: whitten p. J Telemed Telecare. 2008;14(1):50-4. doi: 10.1258/jtt.2007.000001. J Telemed Telecare. 2008. PMID: 18318930 No abstract available.
185 results